Matthew J. Alef

Matthew Alef practices at University of Vermont Medical Center in Burlington, Vermont, part of University of Vermont Health Network.

Matthew Alef's NPI, 1639371610, was assigned on June 1, 2007. Matthew Alef graduated from Rush Medical College in 2005. Matthew Alef's New Hampshire license number on file is 25040.

Matthew Alef's primary practice is University of Vermont Medical Center, at 111 Colchester Ave, Burlington, VT 05401 in Chittenden County. The practice phone is (802) 847-0000.

Matthew Alef's primary practice is University of Vermont Medical Center in Burlington, Vermont, part of University of Vermont Health Network. Matthew Alef is also affiliated with Dartmouth Hitchcock Medical Center. The medical group on file is Dartmouth Hitchcock Clinics Manchester. Dmand AI also links Matthew Alef to 4 more hospitals, 4 medical groups and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Matthew Alef practices, 7 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Matthew Alef's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Matthew Alef is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Matthew Alef's licenses on file in 5 states: New Hampshire, Vermont, New York, Massachusetts and Pennsylvania.

Dmand AI lists amputation, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), heart device and aorta surgery, leg revascularization, peripheral vascular disease and varicose veins among the conditions Matthew Alef treats.

CMS data shows 610 Medicare services from Matthew Alef across 12 procedure codes in 2024, for 494 Medicare patients. Medicare paid $20,633 for them.

CMS counts 494 Medicare patients who saw Matthew Alef in 2024. The largest group is 65 to 74, with 195 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Matthew Alef's median patient age at 69, with 46% women.

In 2024, Matthew Alef wrote 88 Medicare Part D claims for 32 patients. 74% of them were for generic drugs. CMS names the drug for 73 of them, across 3 drugs with 11 or more claims each, at $12,273 in total drug cost. In 2023, CMS named 110 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Matthew Alef for performance year 2024, reported as part of a group. Matthew Alef accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Matthew Alef as offering telehealth. CMS counts 15 procedures of leg revascularization (restoring blood flow) by Matthew Alef, more than 72% of the clinicians it reports for that procedure.

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 16 papers to Matthew Alef, published from 2011 to 2025. 2016 was the busiest year, with 3. The most frequent topics are Aortic Aneurysm, Abdominal, Endovascular Procedures and Blood Vessel Prosthesis Implantation. Matthew Alef has published most often in J Vasc Surg. Matthew Alef's most frequent co-authors are Sara Lauren Zettervall, MD, Daniel Joseph Bertges, MD and Peter A. Soden, MD.

CMS Open Payments shows 71 general payments to Matthew Alef from 13 drug and device companies from 2018 to 2025. Speaker and faculty fees make up the largest share, 49% of the total. Cook Medical LLC paid the most, $17,211.

Dmand AI lists 1 award for Matthew Alef.

Matthew Alef graduated from Rush Medical College in 2005. Matthew Alef is a member of ACS.

Matthew Alef is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.